Amylyx Pharmaceuticals Inc (AMLX)
1.94
-0.03
(-1.52%)
USD |
NASDAQ |
May 08, 13:05
Amylyx Pharmaceuticals Accounts Payable (Quarterly): 22.06M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 22.06M |
September 30, 2023 | 6.371M |
June 30, 2023 | 24.70M |
March 31, 2023 | 10.77M |
December 31, 2022 | 6.257M |
September 30, 2022 | 7.052M |
Date | Value |
---|---|
June 30, 2022 | 8.117M |
March 31, 2022 | 10.04M |
December 31, 2021 | 4.372M |
September 30, 2021 | 3.026M |
December 31, 2020 | 3.613M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.026M
Minimum
Sep 2021
24.70M
Maximum
Jun 2023
9.671M
Average
7.052M
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
Cassava Sciences Inc | 10.57M |
iRhythm Technologies Inc | 8.44M |
Bristol-Myers Squibb Co | 3.539B |
Moderna Inc | 183.00M |
ACADIA Pharmaceuticals Inc | 17.54M |